Valeda PBM Dry AMD Treatment | Precision Eye Group

Advanced Dry AMD Care at PEG Eyecare

Dry age-related macular degeneration (AMD) has long left patients with limited management options beyond lifestyle changes and dietary supplements.

At Precision Eye Group, we offer Valeda Photobiomodulation (PBM) therapy, an innovative technology engineered to support retinal cellular function and help preserve central sight. By delivering targeted, light-based treatments directly to compromised visual tissues, our clinical team helps individuals living with dry AMD protect their visual clarity and maintain daily independence.

If you are living with dry AMD, book an appointment with us today to learn more about Valeda and determine if it is right for you.

Book Appointment

Understanding Dry Age-Related Macular Degeneration

Age-related macular degeneration is a progressive eye condition that affects the macula. This is the central portion of the retina responsible for sharp, straight-ahead vision.

The dry form accounts for the vast majority of AMD cases and develops when microscopic cellular deposits, known as drusen, accumulate beneath retinal tissues. Over time, these deposits hinder nutrient delivery and gradually cause light-sensitive retinal cells to break down.

Because dry AMD is progressive, central vision gradually becomes dim, blurry, or distorted, making everyday tasks like reading, recognizing faces, and driving increasingly challenging.

How Valeda Treats Dry AMD

Valeda uses photobiomodulation (PBM) technology to address the underlying cellular mechanisms of retinal decline.

By delivering three distinct wavelengths of light—yellow (590 nm), red (660 nm), and near-infrared (850 nm)—Valeda stimulates the energy factories, or mitochondria, inside your retinal cells. This light stimulation helps restore cellular energy (ATP) production, boost local circulation, and reduce oxidative stress to improve overall retinal cellular health.

A standard treatment session is comfortable and takes approximately 4 to 5 minutes per eye. Each session moves through four simple phases:

Phase 1: Look at pulses of yellow and near-infrared light for about 30 seconds with your eyes open.
Phase 2: Close your eyes for 90 seconds while a gentle red light shines over the eyelid.
Phase 3: Repeat Phase 1, looking at yellow and near-infrared light pulses for 30 seconds with your eyes open.
Phase 4: Repeat Phase 2, closing your eyes for 90 seconds.

Benefits of Valeda Treatment

Valeda provides a proactive therapeutic option that acts directly at the cellular level.

First and only FDA-authorized treatment: It is the first and only FDA-authorized therapy designed specifically for early and intermediate dry AMD.
Maintains and improves vision: Clinical studies show that treatment helps improve and preserve visual acuity in dry AMD patients over time.
Enhances cellular function: Recharges mitochondrial activity to boost energy production and support retinal cell health.
Completely noninvasive: Requires no eye dilation, topical anesthesia, or injections, with more than 97% of clinical trial participants reporting that they experienced no eye pain.

Are You a Candidate for Valeda?

Determining whether photobiomodulation therapy fits your visual needs requires a detailed evaluation by our optometry team.

You may qualify for Valeda therapy if you:

Have been diagnosed with dry age-related macular degeneration
Are currently in the early to intermediate stages of dry AMD
Do not have major central damage
Have visual acuity between 20/32 and 20/70

Protect Your Central Sight at Precision Eye Group

Living with dry AMD does not mean you have to passively wait for your central vision to decline. With Valeda photobiomodulation, our Pennsylvania team provides targeted care that supports cellular function to protect your visual independence. Scheduling a comprehensive eye exam allows our doctors to assess your retinal health, evaluate your eligibility, and determine if this technology fits your care plan.

Contact Precision Eye Group today to book a consultation with our team at one of our locations to determine if Valeda is right for you.

Book Appointment

Frequently Asked Questions About Dry AMD and Valeda PBM

What is Valeda?

Valeda is an FDA-authorized, noninvasive photobiomodulation (PBM) light therapy system engineered to help manage vision loss in patients with dry age-related macular degeneration (AMD). It applies multi-wavelength light directly to retinal cells without requiring injections, surgery, or eye dilation.

How does Valeda work?

Valeda delivers precise wavelengths of yellow, red, and near-infrared light to activate mitochondria within your retinal cells. This process boosts cellular energy production (ATP), helping reduce inflammation and support overall retinal health.

Does Valeda cure dry AMD?

No, Valeda does not cure dry AMD, as age-related macular degeneration is a progressive, chronic condition. However, clinical studies show that it can help slow disease progression and maintain or improve visual clarity in 84% of patients over 2 years.

How long does treatment take?

Each in-office Valeda therapy session takes approximately 4 to 5 minutes per eye. A standard treatment protocol consists of 9 brief sessions administered over 3 weeks, with periodic maintenance sessions scheduled thereafter.

Is Valeda light therapy safe and comfortable?

Yes, Valeda is a comfortable, noninvasive procedure that causes no eye pain and requires no recovery downtime. Clinical trials have shown consistent safety with no phototoxicity, allowing patients to resume normal daily activities immediately after each visit.

How do I know if Valeda will benefit my eyes?

Valeda is primarily intended for patients with early to intermediate dry AMD who want a proactive option to support their central vision. We encourage you to book a comprehensive eye exam at one of our Precision Eye Group locations to consult with our optometrists and determine if Valeda is right for your visual health.